Yoko Nagashima

Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.

O. Ubukata, S. Iwasaki, Akiko Toyota, 2022, Biochemical and biophysical research communications.